Challenges and opportunities for Indian pharma industry
Dr Swarnlata Saraf, Professor – Pharmaceutics, University Institute of Pharmacy, and Dean, Faculty of Technology, Pt. Ravishankar…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Sun Pharma arm gets US FDA nod for epilepsy drug
The product was filed from Sun Pharma's Halol (Gujarat) facility
Aurobindo Pharma gets US FDA nod for hypokalemia treatment drug
The approved product is a generic version of Upsher-Smith's Klor-Con extended release tablets. Hypokalemia is a condition wherein…
It is imperative for companies today to identify new engines of growth and invest more in…
The complete speech of Dilip Shanghvi as President of 70th Indian Pharmaceutical Congress being held from December 21 to 23, 2018…
Recipharm to end operations in Ashton-under-Lyne facility
The decision to initiate this process has been taken following a strategic review of the operation which has not been profitable…
BASF collaborates with Jagriti Sewa Sansthan
500 young people will embark on an 8,000-kilometre 'Jagriti Yatra'
Mixture of DuPont probiotic strains and Lactoferrin reduces common cause of vaginal discomfort:…
The results showed that symptoms (vaginal discharge and itching) and Nugent score, were significantly improved and BV recurrence…
Lonza publishes IFRS 15 Adoption and Pro-Forma Numbers for Full-Year 2017
The information excluded Water Care Business taking into consideration additional reporting-related items to enable comparison and…
CDSCO initiates action against J&J over baby powder
Draws samples of baby powder from the company's Baddi plant in Himachal Pradesh
Central Drugs Standard Control Organisation…
GSK to split after striking Pfizer consumer health deal
GSK said the deal laid the foundation for the creation of two new UK-based global companies focussed on pharma/vaccines and…
Strides to get $42 m from escrow account after winning arbitration on Agila sale
Strides Pharma Science and its wholly-owned subsidiary completed the sale to Mylan Laboratories and Mylan Institutional of Agila…
Glenmark forays into branded dermatology segment in US
The branded portfolio for the US market will be developed and commercialised by Glenmark Therapeutics USA
European Commission okays Mylan, Biocon’s biosimilar of cancer drug
Ogivri is indicated for the treatment of patients with HER2 positive early breast cancer, metastatic breast cancer and metastatic…
Aptar Pharma to exhibit latest innovations in drug delivery devices at Pharmapack 2019 in Paris
The company will showcase two of their newest product launches, PureHale and QuickStart Injectables
Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Oil
Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its…
Pfizer’s cut-price version of Avastin wins EU panel greenlight
Pfizer's Zirabev is a cheaper version to Roche Holding's leading cancer drug Avastin
Lupin receives US FDA approval for Clobazam tabs
The drug is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients two years…
CX Partners acquires equity stake in Veeda Clinical Research
The investors will make additional investments in the company over a period of time to fund the growth requirements of the company
Glenmark receives ANDA approval for Hydrocortisone Valerate Ointment
The company is eligible for 180 days of CGT exclusivity upon commercialisation
‘Our primary focus is to reach out to customers who have more specific needs’ —…
Bio-Techne empowers researchers in life sciences and clinical diagnostics by providing high-quality reagents, instruments, custom…